Recombinant Ostreococcus lucimarinus 40S ribosomal protein S3a (OSTLU_28528) is a bioengineered variant of the S3a ribosomal protein, a critical component of the 40S ribosomal subunit in eukaryotic translation machinery. Produced via heterologous expression in yeast, E. coli, or other systems, this recombinant protein is widely utilized in molecular biology and structural studies . Its sequence and functional conservation across species make it a valuable tool for investigating ribosome assembly, translation regulation, and extraribosomal activities .
The recombinant protein retains the structural motifs of native S3a, including the conserved eukaryotic S3a family features . Its production in yeast ensures proper post-translational modifications, critical for functional studies .
As part of the 40S subunit, OSTLU_28528 facilitates translation initiation by stabilizing mRNA-ribosome interactions and decoding tRNA codons . Ribosomal proteins like S3a are essential for ribosome biogenesis, with disruptions linked to growth defects in model organisms .
Ribosomal proteins, including S3a homologs, exhibit diverse extraribosomal functions:
DNA Repair: RPS3 (human homolog) cleaves DNA at apurinic/apyrimidinic sites, mitigating oxidative stress .
Immune Modulation: RPS3 interacts with TLR4, enhancing dendritic cell activation and tumor-specific immune responses .
Apoptosis Regulation: RPS3 modulates pro-apoptotic signaling via interactions with transcription factors like E2F1 .
In cancer immunotherapy, RPS3-derived proteins (e.g., human RPS3) are explored as adjuvants in dendritic cell-based vaccines, leveraging their TLR4-binding capacity . While OSTLU_28528’s role in this context is untested, its sequence homology suggests potential utility .
Ribosomal proteins like PsRPs26 (fungal homolog) contribute to fungal pathogenicity by supporting growth and spore production . OSTLU_28528 could serve as a model for studying analogous mechanisms in marine pathogens .
KEGG: olu:OSTLU_28528
STRING: 436017.A4SAD2
OSTLU_28528 is a recombinant protein corresponding to the 40S ribosomal protein S3a from Ostreococcus lucimarinus (strain CCE9901). It is part of the small ribosomal subunit and plays an essential role in protein synthesis. The full-length mature protein consists of 259 amino acids (residues 2-260) and has been successfully expressed in E. coli expression systems to produce the recombinant version with high purity (>85% as determined by SDS-PAGE) .
The protein is associated with several key identifiers that can be used for further research and reference:
UniProt Accession Number: A4SAD2
Product Code (for commercially available recombinant): CSB-EP020444ODL
For optimal stability of OSTLU_28528 recombinant protein, store at -20°C for regular storage. For extended storage periods, it is recommended to conserve the protein at -20°C or -80°C. Working aliquots can be stored at 4°C for up to one week, but repeated freezing and thawing cycles should be avoided as they can compromise protein stability and activity .
For proper reconstitution of OSTLU_28528, follow these methodological steps:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (with 50% being the default recommendation)
Aliquot the reconstituted protein for long-term storage at -20°C/-80°C
This procedure helps maintain protein stability and prevents degradation during experimental procedures .
The shelf life of OSTLU_28528 varies depending on storage form and conditions:
Liquid form: Approximately 6 months when stored at -20°C/-80°C
Lyophilized form: Approximately 12 months when stored at -20°C/-80°C
It's important to note that shelf life is influenced by multiple factors including:
Storage state (liquid vs. lyophilized)
Buffer ingredients
Storage temperature
When designing experiments to study OSTLU_28528 function, follow these methodological steps:
Define your research question and hypotheses clearly (e.g., "How does OSTLU_28528 interact with other ribosomal proteins?")
Identify your variables:
Independent variables: Factors you will manipulate (e.g., protein concentration, buffer conditions)
Dependent variables: Outcomes you will measure (e.g., binding affinity, structural changes)
Control variables: Factors you will keep constant
Control for extraneous variables that might confound your results
Select appropriate experimental methods based on your specific questions (e.g., pull-down assays, circular dichroism, thermal shift assays)
Plan for statistical analysis of your results to ensure reliability and validity
This systematic approach allows for rigorous testing of hypotheses regarding OSTLU_28528 function while minimizing experimental bias and variability .
To investigate protein-protein interactions of OSTLU_28528, consider these methodological approaches:
Co-immunoprecipitation (Co-IP):
Utilize the tag on the recombinant protein (tag type determined during manufacturing)
Pull down OSTLU_28528 and identify interacting partners via mass spectrometry
Surface Plasmon Resonance (SPR):
Immobilize OSTLU_28528 on a sensor chip
Measure real-time binding kinetics with potential interaction partners
Proximity Ligation Assay (PLA):
Detect protein interactions in situ with high specificity
Particularly useful for confirming interactions identified through other methods
Yeast Two-Hybrid (Y2H) screening:
Systematic screening for potential interaction partners
Requires subcloning OSTLU_28528 into appropriate vectors
Each method has specific advantages and limitations, and combining multiple approaches provides more robust evidence of genuine interactions .
To evaluate the role of post-translational modifications (PTMs) on OSTLU_28528, implement these methodological strategies:
Identification of PTM sites:
Perform mass spectrometry analysis to identify potential modification sites
Compare with predicted PTM sites using bioinformatics tools
Site-directed mutagenesis:
Generate mutants where potential PTM sites are altered
Express and purify these mutants following the same protocols as wild-type
Functional comparison:
Design assays comparing wild-type and mutant proteins
Measure parameters such as:
Binding affinities
Structural stability
Ribosomal incorporation efficiency
In vivo validation:
Develop cellular assays to assess the biological relevance of identified PTMs
Consider using CRISPR/Cas9 to introduce mutations at PTM sites in the native gene
This systematic approach allows researchers to establish causal relationships between specific modifications and functional outcomes .
Expression of OSTLU_28528 in different systems presents specific challenges that can be addressed through these methodological approaches:
| Expression System | Common Challenges | Mitigation Strategies |
|---|---|---|
| E. coli | - Inclusion body formation - Improper folding - Low solubility | - Optimize induction conditions (temperature, IPTG concentration) - Use solubility-enhancing fusion tags (MBP, SUMO, etc.) - Consider codon optimization for E. coli |
| Yeast | - Hyperglycosylation - Lower yield than E. coli - Longer expression time | - Use specific strains (SMD1168, GS115, X-33) - Optimize promoter selection - Adjust growth media composition |
| Insect cells | - More complex culture conditions - Higher cost - Viral stock maintenance | - Select appropriate cell lines (Sf9, Sf21, High Five) - Optimize MOI (multiplicity of infection) - Monitor and maintain cell viability |
| Mammalian cells | - Lowest yield - Highest complexity - Highest cost | - Choose appropriate cell lines (293, 293T, CHO) - Consider stable vs. transient expression - Optimize transfection efficiency |
For OSTLU_28528 specifically, E. coli expression has been successfully demonstrated, but other systems may be explored based on specific research needs and goals .
To investigate OSTLU_28528's role in ribosome assembly and function, implement these methodological approaches:
Reconstitution experiments:
Perform in vitro ribosome assembly with and without OSTLU_28528
Analyze assembly intermediates using sucrose gradient centrifugation
Quantify assembly efficiency under various conditions
Structure-function studies:
Generate domain deletion or point mutation variants
Assess their impact on:
Ribosome assembly
Translation efficiency
Interaction with specific rRNAs or proteins
Cryo-electron microscopy:
Determine structural changes in ribosomes with wild-type vs. mutant OSTLU_28528
Identify precise positioning and contacts within the ribosomal complex
Translation assays:
Measure translation rates and fidelity using reporter systems
Compare systems with wild-type vs. depleted or mutant OSTLU_28528
These approaches provide complementary insights into both structural and functional aspects of OSTLU_28528's role in ribosome biology .
For robust statistical analysis of OSTLU_28528 experimental data, follow these methodological guidelines:
Experimental design considerations:
Ensure adequate replication (minimum n=3 for most experiments)
Include appropriate controls (positive, negative, vehicle)
Consider power analysis to determine sample size
Data preprocessing:
Assess normality of data distribution (Shapiro-Wilk or Kolmogorov-Smirnov tests)
Check for outliers and determine appropriate handling
Transform data if necessary to meet assumptions of parametric tests
Statistical test selection:
For comparing two groups: t-test (parametric) or Mann-Whitney U test (non-parametric)
For multiple groups: ANOVA with appropriate post-hoc tests (Tukey's, Bonferroni, etc.)
For correlation analysis: Pearson's (parametric) or Spearman's (non-parametric)
Advanced analyses for complex experiments:
Repeated measures designs: RM-ANOVA or mixed models
Dose-response experiments: Nonlinear regression analysis
High-dimensional data: Principal component analysis or other dimensionality reduction methods
When faced with contradictory results in OSTLU_28528 studies, apply this systematic framework:
Methodological differences assessment:
Compare experimental conditions (pH, temperature, buffer composition)
Evaluate protein preparation methods (tags, purification protocols)
Assess expression systems used (bacterial vs. eukaryotic)
Technical validation:
Verify protein quality (purity, aggregation state, activity)
Confirm antibody specificity if immunological methods were used
Check for batch-to-batch variations in reagents
Biological context considerations:
Examine cell/tissue type differences
Consider developmental or physiological states
Evaluate potential species-specific differences
Integration of multiple techniques:
Compare in vitro vs. in vivo findings
Triangulate results using orthogonal methods
Weight evidence based on methodological rigor
Computational analysis:
Perform meta-analysis if multiple datasets are available
Use machine learning approaches to identify patterns not obvious in individual experiments
This comprehensive approach helps resolve apparent contradictions and develops a more nuanced understanding of OSTLU_28528 biology .
OSTLU_28528 can be strategically employed in structural biology through these methodological approaches:
Cryo-EM studies:
Use purified OSTLU_28528 in ribosome reconstitution experiments
Generate ribosomes with labeled or modified S3a for localization
Compare structures with wild-type vs. mutant proteins to identify conformational changes
X-ray crystallography:
Attempt crystallization of OSTLU_28528 alone or in complex with interacting partners
Use selenomethionine-labeled protein for phase determination
Employ surface entropy reduction to improve crystal quality
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Map dynamic regions and binding interfaces
Compare solvent accessibility patterns in free vs. ribosome-bound states
Identify allosteric effects of ligand binding
Integrative structural biology:
Combine data from multiple techniques (cryo-EM, NMR, SAXS, etc.)
Develop computational models incorporating experimental constraints
Validate models through directed mutagenesis and functional assays
These approaches can reveal insights into both the structure of OSTLU_28528 itself and its contribution to ribosome architecture and function .
When designing target engagement studies for OSTLU_28528, implement these methodological principles:
Assay development:
Establish quantitative methods to measure free vs. bound OSTLU_28528
Consider fluorescence polarization, thermal shift, or ELISA-based approaches
Validate assays using known interaction partners
Experimental design:
Define clear hypotheses about target binding
Include appropriate controls (non-binding mutants, competitive inhibitors)
Plan for concentration-response relationships
Sample collection and preparation:
For cellular studies, optimize lysis conditions to preserve interactions
For tissue studies, consider rapid preservation methods
For in vivo studies, develop appropriate sampling timelines
Analysis considerations:
Calculate target engagement parameters (Kd, Bmax, etc.)
Assess engagement kinetics if time-course data is available
Compare engagement across different experimental conditions
These approaches allow researchers to quantitatively assess how OSTLU_28528 interacts with its biological targets under various conditions .